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β-karyopherinInactivation of S. cerevisiae β-karyopherin Msn5 causes hypersensitivity to the overexpression of mitotic cy-
clin Clb2 and aggravates growth defects of many mutant strains in mitotic exit, suggesting a connection be-
tween Msn5 and mitotic exit. We determined that Msn5 controlled subcellular localization of the mitotic exit
transcription factor Swi5, since it was required for Swi5 nuclear export. Msn5 physically interacted with the
N-terminal end of Swi5. Inactivation of Msn5 caused a severe reduction in cellular levels of Swi5 protein. This
effect occurred by a post-transcriptional mechanism, since SWI5mRNA levels were not affected. The reduced
amount of Swi5 in msn5mutant cells was not due to an increased protein degradation rate, but to a defect in
Swi5 synthesis. Despite the change in localization and protein level, Swi5-regulated transcription was not de-
fective in the msn5 mutant strain. However, a high level of Swi5 was toxic in the absence of Msn5. This del-
eterious effect was eliminated when Swi5 nuclear import was abrogated, suggesting that nuclear export by
Msn5 is important for cell physiology, because it prevents toxic Swi5 nuclear accumulation.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The periodic oscillation of several cyclin-dependent kinase (CDK)
activities governs progression through the different cell cycle transi-
tions. A common hallmark of mitotic exit in all eukaryotic cells is a dra-
matic reduction in overall CDK activity [1]. In Saccharomyces cerevisiae,
Clb2-Cdc28 kinase is themost important mitotic CDK activity. Its inacti-
vation at the end ofmitosis is accomplished by twomechanisms: degra-
dation of Clb2 and the other Clb cyclins by the ubiquitin-ligase APC, and
kinase inhibition by the CDK inhibitor Sic1. This process is controlled by
the Cdc14 phosphatase, which is activated at the end of mitosis by the
mitotic exit network (MEN). Cdc14 acts on the APC activator Cdh1,
the Sic1 protein, and the transcription factor Swi5 (responsible for ex-
pression of the SIC1 gene) to trigger cyclin degradation and Sic1 accu-
mulation [2-5].
Sic1 abundance is cell cycle-regulated and peaks at the end of mito-
sis. This periodicity results from stage-speciﬁc degradation of the pro-
tein and regulated transcription of the gene [6]. SIC1 gene expression
is controlled by the Swi5 transcription factor [7,8]. Swi5 was originally
identiﬁed as one of the transcription factors involved in HO endonucle-
ase expression [9]. However, it plays a more general role, since it is re-
sponsible, together with transcription factor Ace2, for a transcriptional
wave at the end of the cell cycle, which includes many genes that en-
code important regulators of the M/G1 transition, such as the above-ia Molecular, Facultat de Cièn-
50, E-46100 Burjassot, Spain.
rights reserved.mentioned inhibitor Sic1 [10]. Swi5 and Ace2 are related proteins.
They contain a similar zinc ﬁnger domain and show functional redun-
dancy [11,12]. In fact, both factors jointly activate the transcription of
many genes. However, the expression of other genes is speciﬁcally reg-
ulated by either Swi5 or Ace2 [11,13,14]. Speciﬁc functions may arise
from differences in their spatial regulation [15-17] or interacting part-
ners [12,18].
The participation of Swi5 in both sexual differentiation and cell cycle
regulation has resulted in extensive studies of this transcription factor.
Swi5 is a 709-amino acid protein with a modular architecture. The C-
terminal third of the protein contains both a zinc ﬁnger domain [19]
and a classical nuclear localization signal (NLS). The central segment
of the protein meditates interactions with Pho2 and plays an important
role in the full transcriptional activation of the HO gene [18,20]. Swi5
also contains a region rich in serines, which are phosphorylated by
Pho85 CDK and mediate Swi5 activity and stability [16,21]. However,
little is known about the function of the N-terminal third of Swi5.
Swi5 is regulated at several levels. The SWI5 gene is periodically
transcribed at the G2-M transition [22] by Fkh2–Mcm1–Ndd1 tran-
scription factors [10]. The newly synthesized Swi5 is located in the cy-
toplasm until the end of mitosis, when Swi5 enters the nucleus to act
as a transcriptional activator [23]. Some of the mechanisms control-
ling the subcellular localization of Swi5 have been determined. The
Swi5 NLS is inactivated by phosphorylation of the serines 552, 646,
and 664 by Clb-Cdc28 CDK, which prevents Swi5 nuclear accumula-
tion in the G2/M phase [24]. At the end of mitosis, Cdc14 phosphatase
dephosphorylates these serine residues, which triggers the nuclear
import of Swi5 by the classical import pathway [25,26]. The Swi5 nu-
clear signal decreases during G1, which led to the idea that Swi5
would be degraded once it enters the nucleus [23]. Recently, Swi5
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this process is controlled by the Pho85-dependent phosphorylation of
the serine-rich central region [16,27]. Swi5 degradation seems to be
important for entry into S phase [27].
Transport of proteins into and out of the nucleus is an active pro-
cess that occurs through the nuclear pore complex (NPC). It is facili-
tated by soluble transport receptors of the β-karyopherin family. β-
karyopherins act as importins or exportins by recognizing speciﬁc
features in their cargoes: NLS or nuclear export signals (NES), respec-
tively [28-30]. The binding and release of cargo proteins by karyo-
pherins is controlled by the Ran GTPase cycle. Importins bind cargo
in the cytosol and release it in the nucleoplasm by interactions with
Ran-GTP. In the export process, the binding of cargo by karyopherins
in the nucleus is stabilized by Ran-GTP and, once in the cytoplasm,
hydrolysis of GTP to GDP triggers dissociation of the cargo [31].
Msn5 is a member of the β-karyopherin family and has been asso-
ciated with different cellular processes. It participates in different as-
pects of cell cycle control by mediating nuclear export of the Start
transcription factors Swi6 and Whi5 [32,33], the CKI inhibitor Far1
[34], the APC activator Cdh1 [35] and the HO endonuclease [36].
Msn5 also controls nuclear export of the transcription factors Pho4
[37], Crz1 [38], Mig1 [39], Msn2/4 [40], Rtg1/3 [41], Aft1 [42], and
Maf1 [43], which are involved in phosphate metabolism, calcium sig-
nalling, glucose repression, stress response, nitrogen regulation, iron
response and RNApol III transcription, respectively. In addition to its
role in protein export, Msn5 may play a secondary role in the export
of tRNA [44]. Consistent with this, Msn5 and its mammalian ortholo-
gue Exportin-5 can bind tRNA and other RNAs [45].
In the present work, we described a new connection of Msn5 with
cell cycle control.Msn5 is involved in the regulation of the subcellular lo-
calization and protein levels of the late mitosis transcription factor Swi5.
2. Materials and methods
2.1. Yeast strains and plasmids
The yeast strains used in this study are shown in Supplemental
Material Table 1. Themsn5mutant strains were obtained by integrat-
ing a DNA fragment ampliﬁed from a strain containing the msn5Δ3::
HIS3 disruption cassette, originally obtained by using plasmids
p335-Δ3::HIS3 (from Dr. F. Estruch). The swi5, sic1 and cdh1 mutant
strains were obtained by integrating a DNA fragment ampliﬁed from
plasmid pFA6a-kanMX6 (from Dr. J.R. Pringle). Strains expressing
the Msn5, the Swi5 protein or truncated versions of the protein
from the GAL1 promoter, N-terminal or C-terminal tagged with HA
or myc epitopes, were constructed by integrating at the appropriate
position a DNA fragment ampliﬁed from the pFA6a series plasmids
(a gift from Dr. J.R. Pringle).
Plasmids used in the two-hybrid assay expressing different frag-
ments of Swi5 fused to the Gal4 activation domain were obtained
by cloning DNA fragments coding for the indicated regions of Swi5,
which were ampliﬁed from genomic DNA using a forward oligo con-
taining an EcoRI restriction site and a reverse oligo containing a
BamHI restriction site, into EcoRI–BamHI digested pGAD-C1. pBD-
MSN5 expressing Msn5 fused to the Gal4 DNA-binding domain was
a gift from Dr. M. Johnston.
Plasmid pSWI5AAA expressing a mutated Swi5 protein in which
Ser 522, 646 and 664 have been substituted by Ala was a gift from
Dr. L.H. Johnston. Plasmid HO(31)-CYC1-lacZ (M1853) contains the
Swi5 binding site from the HO promoter in front of the lacZ gene
[18].
2.2. β-galactosidase assays
Approximately 108 cells were harvested, washed with water and
resuspended in 200 μL of Z buffer (60 mM Na2HPO4, 40 mMNaH2PO4·H2O, 10 mM KCl, 1 mM MgSO4, 0.1% β-mercaptoethanol,
pH 7) containing 1 mg/mL of zymolyasa-20 T. After 20 min of incuba-
tion at 30 °C, extracts were centrifuged and the supernatants were
conserved. Different quantities of extracts (20–180 μL) were taken
and Z buffer was added up to 900 μL. Reaction was started by the ad-
dition of 180 μL of 4 mg/mL ONPG (o-nitrophenyl-β-D-galactopirano-
side). Samples are incubated at 30 °C until they become yellow
colored. The reaction was stopped with 450 μL of Na2CO3 1 M and
the A420 was determined. Activity is expressed in U/mg of protein
where 1U is deﬁned as A420×103/min of incubation. Protein concen-
tration was determined by Bradford assay.
2.3. Northern blot analysis
Approximately 108 exponentially growing cells were collected,
resuspended in 500 μL of LETS (0.1 M LiCl, 10 mM EDTA, 0.2% SDS,
10 mM Tris–HCl pH 7.4), mixed with 500 μL of phenol:chloroform:
isoamylic alcohol (125:24:1) and broken by vigorous shaking with
glass beads. After two extraction with one volume of phenol:chloro-
form:isoamylic alcohol and one volume of choloform:isoamyl alcohol
(24:1), RNA was precipitated with 0.1 volume of 5 M LiCl and 2.5 vol-
ume of cold 100% ethanol at least for 3 hours at−20 °C. RNA was col-
lected by centrifugation, washed with 70% ethanol, resuspended in
30 μl of water and quantiﬁed. 5 μg of total RNA was fractionated on
agarose gel containing formaldehyde and transferred to Hybond-N
membrane (Amersham). SWI5, SIC1 and ACT1 mRNA were detected
using 32P-labeled probes obtained with HighPrime (Roche) according
to the manufacturer instructions and quantiﬁed in a FLA3000 Phos-
phorImager (Fujiﬁlm).
2.4. Coimmunoprecipitation
Approximately 5×108 cells expressing Swi5-myc and either
untagged or HA epitope-tagged versions of Msn5 were resuspended
in 100μL of 50 mM Tris–HCl pH 8, 250 mM NaCl, 5 mM EDTA, 0,1%
Triton X-100, 1 mM PMSF and 5 μg/mL Complete mixture (Roche Ap-
plied Science) and broken with vigorous shaking in the presence of
glass beads. Cellular debris was removed and the supernatant was
clariﬁed by centrifugation at 13,000×g for 5 min. Dynabeads Protein
G magnetic beads (50 μL) were sequentially washed twice with
phosphate-buffered saline containing Tween 0.02%, incubated with
rat monoclonal anti-HA 3F10 antibody for 20 min at room tempera-
ture and after extensive washing incubated with the cell extract for
20 min at room temperature. After washing beads, the immunopreci-
pitated proteins were eluted by boiling the beads for 5 min in loading
buffer and analyzed by SDS-polyacrylamide gel electrophoresis fol-
lowed by Western blot analysis.
2.5. Miscellaneous
Indirect immunoﬂuorescence and western blot analysis were car-
ried out as described previously [46]. Antibodies used in westerns as-
says were anti-HA 12C5A antibody (Roche), an anti-Swi5 antibody
(form Dr. D. Stillman), anti-PSTAIRE antibody (Santa Cruz) or anti
α-tubulin antibody (Serotec Ltd.). Bands were quantiﬁed in non-
saturated ﬁlms using Quantity One software (Biorad) or in an Image-
Quant LAS4000 biomolecular imager (GE Healthcare). Antibodies
used in immunoﬂuorescence assays were anti-HA 3F10 antibody
(Roche) or mouse anti-myc 9E10 (Roche).
3. Results
3.1. Genetic interactions connect Msn5 karyopherin with mitotic exit
Impaired growth in the presence of high levels of the cyclin Clb2 is
a typical characteristic of strains containing mutations in genes
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msn5 mutant strain in relation to cell cycle progression, we investi-
gated the effect of Clb2 overexpression. When high levels of Clb2
were induced by galactose in cells containing a GAL1:CLB2 gene,
growth was severely impaired in the absence of Msn5 (Fig. 1A).
This defect was not due to a change in the carbon source, because it
was not observed in cells containing a control plasmid; rather, it indi-
cates that msn5 cell growth was hypersensitive to high levels of Clb2.
In support of this, defective growth was rescued by reintroduction of
a functional copy of the MSN5 gene. The growth defect observed in
the msn5 mutant was very similar to that observed in strains with
mutations in genes involved in mitotic exit, such as the sic1 and
swi5 mutants; however, the growth defect was less severe than that
seen in a mutant in APC activator Cdh1.
The previous result suggested that the Msn5 karyopherin might be
associated with mitotic exit. To further investigate this connection,
we carried out a synthetic interaction assay between the msn5 muta-
tion and the mutations in several genes involved in mitotic exit. The
MSN5 gene was inactivated in strains with mutations in the phospha-
tase Cdc14, the kinase Cdc15 (a component of the MEN pathway) or
the APC ubiquitin ligase subunits Apc2, Cdc20, or Cdh1. Growth atFig. 1. Genetic interactions between MSN5 and mitotic exit genes. A) 10-fold serial dilution
(JCY920), sic1 (JCY316) and cdh1 (JCY1012) strains transformed with an empty vector or a p
onto YPD or YPGal medium and incubated at 28° for 3 days. B) 10-fold serial dilutions fr
cdc14msn5 (JCY676), cdc15, cdc15msn5 (JCY674), cdc20, cdc20msn5 (JCY672), cdh1 (JCY101
the indicated temperature for 3 days. The apc2 (KTM200U) and apc2msn5 (JCY744) strainshigh temperature revealed that none of the double mutants, msn5
cdc14,msn5 cdc15,msn5 apc2,msn5 cdc20 ormsn5 cdh1, grew proper-
ly compared to the single mutant strains (Fig. 1B). Defective growth
was rescued by the reintroduction of a functional copy of the MSN5
gene. Msn5 was also inactivated in the CDK inhibitor Sic1 and mitotic
exit transcription factor Swi5 mutant strains. However, no synthetic
growth defect was observed in the msn5 sic1 and msn5 swi5 double
mutant strains. These results indicate a synthetic interaction between
the msn5 mutation and the cdc14, cdc15, cdc20, apc2, and cdh1 muta-
tions, which reinforces the idea that Msn5 participates in an essential
function with mitotic exit genes.
3.2. Msn5 controls the subcellular localization of Swi5
Msn5 has been reported to be involved in the nuclear export of
Cdh1. However, two observations suggest that this mechanism
alone cannot explain the link between Msn5 and mitotic exit: ﬁrst,
accumulation of Cdh1 in the nucleus in a msn5 mutant strain is asso-
ciated with higher APCCdh1 activity [35], which is inconsistent with
hypersensitivity of msn5 to high levels of Clb2; second, the synthetic
interactions between msn5 and cdh1 mutations suggest that Msn5s from exponentially growing cultures of wild type (W303-1a), msn5 (JCY1018), swi5
lasmid expressing the CLB2 gene under the control of the GAL1 promoter were spotted
om exponentially growing cultures of wild type (W303-1a), msn5 (JCY1018), cdc14,
2) and cdh1msn5 (JCY1014) strains were spotted onto YPD medium and incubated at
were streaked in YPD plates and incubated at the indicated temperatures.
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transcription factor Swi5, which is responsible for a transcriptional
wave at the end of mitosis that includes the SIC1 gene. A putative in-
teraction between Msn5 and Swi5 was reported in two-hybrid global
analysis [48]. Given the high number of false positives in the genome-
wide analysis, our ﬁrst aim was to conﬁrm the existence of a physical
interaction between Msn5 and Swi5 by a two-hybrid assay. The strat-
egy we designed involved the expression of Swi5 fused to the Gal4 ac-
tivation domain (GAD) in the presence of Msn5 fused to the Gal4
DNA-binding domain (BD), and analysis of the expression of a GAL7:
lacZ gene. It should be noted that the presence of Msn5-BD led to a
signiﬁcant level of β-galactosidase activity, which was probably due
to Msn5 interacting with several transcription factors. However, β-
galactosidase activity signiﬁcantly increased when both the Swi5-
GAD and Msn5-BD proteins were present (Fig. 2A), demonstrating
that Msn5 physically interacts with Swi5 in vivo.
To further investigate the interaction between Msn5 and Swi5,
we carried out a coimmunoprecipitation experiment. Crude extracts
were prepared from cells expressing an HA-tagged Msn5 protein
and from control cells with untagged Msn5. The HA-Msn5 protein
was immunoprecipitated, and the presence of Swi5 in the puriﬁed
fraction was determined by western blot analysis. As shown in
Fig. 2B, Swi5 selectively coimmunoprecipitated with HA-Msn5.
These results provide further support for Msn5 physically interact-
ing with Swi5 in vivo. We also carried out an in vitro binding ex-
periment between GST-Msn5, His6-Swi5 and His6-Gsp1/Ran
expressed in bacteria. No speciﬁc interaction between Msn5 and
Swi5 could be detected, which raises the possibility that the inFig. 2. Physical interaction between Swi5 and karyopherin Msn5. A) The two-hybrid
strain PJ69-4A was transformed with plasmids expressing Swi5 fused to the Gal4 acti-
vation domain (pGAD–SWI5), Msn5 fused to the Gal4 DNA-binding domain (pBD-
MSN5) and the corresponding empty vector (pGAD and pBD) as indicated. The ability
of the proteins to induce expression of a GAL7:lacZ gene was tested by measuring β-
galactosidase activity in extracts from exponentially growing cells. B) Msn5 was immu-
noprecipitated with anti-HA antibody from crude extracts of cells expressing a HA-
tagged Msn5 (JCY520) and the control strain (JCY927). The presence of myc-tagged
Swi5 and HA-tagged Msn5 in the input, unbound and immunoprecipitated fractions
was determined by western analysis with a speciﬁc anti-myc or anti-HA antibody.
Note that both Msn5 and Swi5 are over-expressed.vivo interaction between Msn5 and Swi5 could involve either addi-
tional bridging protein(s) or, most probably, a post-translational
modiﬁcation of Swi5 as occurs with other Msn5 cargo proteins
[36-39,42,43].
Given that Msn5 is a karyopherin, its in vivo physical interaction
with Swi5 raises the possibility that Msn5 may control the subcellu-
lar localization of the transcription factor. Therefore, we decided to
investigate the localization of Swi5 in the absence of Msn5. Swi5 is
a periodic protein whose levels oscillate throughout the cell cycle.
As with other cell cycle regulators, the localization of Swi5 also var-
ies throughout the cell cycle. The protein begins to accumulate in the
cell in the G2/M phase. During G2/M, Swi5 remains cytosolic until it
enters the nucleus at the end of mitosis. It remains nuclear during
G1, which is coincident with its degradation [19,23]. To analyze the
possible effects of Msn5 on Swi5 localization, we expressed Swi5
under the control of the GAL1 promoter to ensure constitutive ex-
pression during the cell cycle. This altered expression of the gene
did not change the cell cycle-regulated localization pattern of Swi5
[23]: the wild-type strain showed nuclear localization of Swi5 only
during telophase and G1, but the protein was cytosolic in the other
cell cycle stages. In contrast, in the msn5 mutant cells, Swi5 was
detected inside the nucleus during all cell cycle stages, although
the nuclear signal was weaker or absent in a number of large-
budded cells (Fig. 3A). This result was conﬁrmed by analysis of
Swi5 localization in α-factor synchronized cells (Fig. 3B). The ob-
served Swi5 nuclear localization in all cell cycle stages in msn5
cells could be due to the inactivation of an export mechanism or to
the constitutive nuclear import of Swi5 along the whole cell cycle.
However, the fact that Swi5 remain cytosolic in nocodazole-
arrested msn5 cells ruled out the latter possibility (Supp. Fig. 1A).
It has to be noted that a small percentage of nocodazole-arrested
cells (13%) showed a nuclear signal, which could be due to nuclear
import block leakage. In summary, the increased nuclear localization
of Swi5 in the absence of Msn5 indicates that Msn5 is involved in
the nuclear export of Swi5. The detected physical interaction be-
tween the two proteins described above suggests that requirement
of Msn5 for Swi5 export is not an indirect effect; rather, Swi5 prob-
ably is a direct cargo of Msn5.
3.3. The N-terminal region of Swi5 mediates interaction with Msn5 and
nuclear export
In a ﬁrst attempt to identify the region of Swi5 responsible for its
nuclear export, we did a two-hybrid assay to test the ability of dif-
ferent Swi5 fragments to interact with Msn5. Initially, Swi5 was di-
vided into two complementary parts: the ﬁrst including amino
acids 1–325, and the second covering amino acids 326–709. β-
galactosidase activity in the extracts of cells containing GAD–
Swi5326–709 was similar to that observed in control cells bearing
the empty pGAD vector. This is not due to a defect in the expression
of the fusion protein (Supp. Fig. 1B). However, β-galactosidase activ-
ity was signiﬁcantly greater in cells expressing the GAD–Swi51–325
fusion product (Fig. 4A). These results indicate that amino acid re-
gion 1–325 of Swi5 is necessary and sufﬁcient to mediate the inter-
action between Swi5 and Msn5.
To further delineate the Msn5-interacting region of Swi5, we also
analyzed the ability of Swi5 fragments 1–285, 1–224, and 1–165 to in-
teract with Msn5. As Fig. 4A shows, the GAD–Swi51–285 fusion prod-
uct was still able to interact with Msn5, although β-galactosidase
activity was lower than that obtained with the whole protein or
with region 1–325. However, extracts from cells expressing fusion
products GAD–Swi51–224 and GAD–Swi51–165 contained similar β-
galactosidase activities to those observed with the control empty
pGAD vector. Thus, the result indicates that region 224–285 is neces-
sary for the interaction between Swi5 and Msn5. To determine
whether this region is also sufﬁcient for the interaction, we
Fig. 3. Control of the subcellular localization of Swi5 by karyopherin Msn5. A) The GAL1:SWI5-HA (JCY1162) and the GAL1:SWI5-HA msn5 (JCY1499) strains expressing a HA-tagged
version of Swi5 under the control of the GAL1 promoter were grown on rafﬁnose. Galactose was added to a ﬁnal concentration of 2% and after 60 min, cells were assayed by indirect
immunoﬂuorescence. The HA indirect-ﬂuorescence signals (α-HA), the DAPI staining of DNA and the DIC images are shown. White arrows mark examples of G2/M cells with nu-
clear signal. No signal was detected in a control of the untagged wild type strain. Graph represents the percent of cells (n>500 from three independent samples) with nuclear signal
at the different stages of the cell cycle. B) Cultures of the GAL1:SWI5-HA (JCY1162) and the GAL1:SWI5-HA msn5 (JCY1499) strains grown on rafﬁnose were synchronized by the
addition of α-factor. After two hours galactose was added to a ﬁnal concentration of 2% and after and additional 30 min incubation cells were released from the arrest and assayed
by indirect immunoﬂuorescence at the indicated time. The percent of cells with nuclear signal is indicated.
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galactosidase activity obtained with this protein demonstrates that
this region did not interact with Msn5 in the two-hybrid assay. The
same result was obtained with an extended region from amino acid
224 to 325. This is not due to lack of expression since both proteins
are expressed at a similar level than GAD–Swi5 (Supp. Fig. 1B). Rath-
er, these results suggest that, in addition to fragment 224–285, someelement present in region 1–224 of Swi5 may play an important role
in the interaction between Msn5 and Swi5.
The interaction between the N-terminal end of Swi5 and Msn5
suggests that the N-terminal region of the transcription factor acts
as an NES. If this were true, the absence of this region would cause
the nuclear localization of Swi5 during all cell cycle phases. To verify
this prediction, we investigated the localization of a truncated version
Fig. 4. Characterization of the Swi5 region interacting with Msn5. A) The interaction between Msn5 fused to the Gal4 DNA-binding domain and different truncated forms of Swi5
fused to the Gal4 activation domain was analyzed by two-hybrid analysis as described in Fig. 2. B) Cells expressing a myc-tagged version of the full length Swi5 (JCY1135) or the
truncated Swi5326–709 (JCY1138) protein under the control of the GAL1 promoter were grown on galactose and assayed by indirect immunoﬂuorescence. The myc indirect-
ﬂuorescence signals (α-myc), the DAPI staining of DNA and the DIC images are shown. White arrows mark examples of G2/M cells with nuclear signal. No signal was detected
in a control untagged strain. Graph represents the percent of cells (n>250 from two independent samples) with nuclear signal at the different stages of the cell cycle.
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Swi5 protein was nuclear only in telophase and G1, in the case of
the Swi5326–709 protein, nuclear signal was also observed in other
cell cycle phases, although the nuclear signal was weaker in a number
of large-budded cells (Fig. 4B). This result indicates that region 1–325
of Swi5 is required for proper localization of the protein throughout
the cell cycle, which is consistent with the interaction detected be-
tween fragment 1–325 of Swi5 and Msn5. However, fragment
1–325 was unable to drive the nuclear export of a nuclear chimeric
protein composed of four copies of the GFP protein fused to the NLS
from SV40. This could suggest that additional sequences are involved
in nuclear export activity. Alternatively, this result could also be
caused by a stronger NLS than NES activity. Because of that we
fused the 1–325 fragment to GFP in order to analyze whether 1–325
fragment could keep a protein lacking a functional NLS out of the nu-
cleus in an Msn5 dependent manner. Surprisingly, the Swi51–325–GFP
fusion protein showed a nuclear localization (Supp. Fig. 1C). Thus, the
1–325 region must contain a cryptic NLS. However, this cryptic NLS is
not probably affecting Swi5 localization since Swi5 nuclear accumula-
tion is dependent on the well-known C-terminal NLS since its dele-
tion abolishes Swi5 nuclear accumulation (Supp. Fig. 2B), whereas
deletion of 1–325 fragment does not impede Swi5 nuclear accumula-
tion. We quantiﬁed the nuclear and cytosolic signal intensity in order
to evaluate the NES activity of fragment Swi51–325 (Supp. Fig. 1C). In-
terestingly, nuclear/cytosolic signal intensity ratio was higher inmsn5mutant (2.70±0.21) than in wild type cells (2.28±0.20), which is
consistent with the presence of an Msn5-dependent NES in the
Swi51–325 fragment.
3.4. Reduced Swi5 protein levels in msn5 mutant cells
In parallel to the experiments described above, we analyzed Swi5
protein by western blotting. As shown in Fig. 5A, the amount of Swi5
in msn5 mutant cells is signiﬁcantly lower compared to that in the
wild-type cells. The effect of Msn5 inactivation on the Swi5 protein
level was strikingly observed in a GAL1:MSN5 strain: after glucose ad-
dition, the decrease in Swi5 paralleled the disappearance of Msn5
protein (Fig. 5B). Given that SWI5 is a periodically expressed gene,
the reduced Swi5 protein level in msn5 mutant cells could be caused
by a change in the cell cycle distribution of cells. However, this was
not the case, because we did not observe a signiﬁcant change in the
cell cycle distribution of cells. Alternatively, the lower level of Swi5
in the absence of Msn5 could be attributed to a defect in SWI5 gene
expression. To investigate this possibility, we analyzed the Swi5 pro-
tein levels when the MSN5 gene was ectopically expressed under the
control of the GAL1 promoter. Western blotting revealed that inacti-
vation of Msn5 led to lower amounts of Swi5 (Fig. 5C). More impor-
tantly, a northern analysis done in parallel revealed that SWI5
mRNA levels in the msn5 mutant strain was not markedly affected
(Fig. 5A, C). These results rule out the possibility of alterations in
Fig. 5. Analysis of Swi5 protein level in themsn5mutant cells. A) The level of Swi5 protein and the SWI5mRNA in crude extracts of cells from exponentially growing cultures of the
wild type (W303-1a) and themsn5mutant (JCY1018) strains was determined by western or northern analysis respectively. A non-speciﬁc band labeled with an asterisk that cross-
react with the anti-Swi5 antibody and actin mRNA is shown as loading controls. Graph represents the amount of Swi5 protein (relative to the non-speciﬁc band) and SWI5 mRNA
(relative to ACT1 mRNA) in the msn5 mutant strain relative to the wild type strain. B) GAL1:HA-MSN5 (JCY313) cells bearing a plasmid that express a HA-tagged version of Swi5
were grown on galactose and transferred to glucose containing medium to repress MSN5 gene expression. The level of Msn5 and Swi5 proteins in crude extracts was determined
at the indicated time by western analysis. A control extract from the wild type untagged strain (wt) and a loading control (asterisk) are shown. C) The GAL1:HA-SWI5 (JCY1117) and
the GAL1:HA-SWI5 msn5mutant (JCY1120) cells expressing a HA-tagged version of Swi5 under the control of the GAL1 promoter were grown on galactose and the level of the Swi5
protein and the SWI5mRNA in crude extracts was determined in the same samples by western or northern analysis respectively. Tubulin and actin mRNA is shown as loading con-
trols. Graph represents the amount of Swi5 protein (relative to tubulin) and SWI5mRNA (relative to ACT1mRNA) in the msn5mutant strain relative to the wild type strain. D) The
level of Ace2, Swi6 or Whi5 proteins in crude extracts from cells of the GAL1:HA-ACE2 (JCY592), SWI6-HA (JCY 710), WHI5-HA (JCY1346) and their corresponding msn5 mutant
strains (JCY590, JCY287 and JCY1348) was determined by western analysis. A non-speciﬁc band labeled with an asterisk that cross-react with the antibody is shown as loading con-
trol. E) The level of different truncated Swi5 proteins in crude extracts of cells from exponentially growing cultures was determined by western analysis. Strains used were GAL1:
SWI5-HA (JCY1162), GAL1:SWI51–634-HA (JCY1163), GAL1:SWI51–551-HA (JCY1165), GAL1:SWI51–422-HA (JCY1491), GAL1:HA-SWI5326–709 (JCY1495), GAL1:HA-SWI5423–709 (JCY1175)
and their corresponding msn5 mutant strains (JCY1499, JCY1501, JCY1177, JCY1503 JCY1507 and JCY 1181 respectively). Also included are the wild type (W303-1a) and the msn5
(JCY1018) strains transformed with a plasmid expressing the constitutive nuclear Swi5AAA mutant protein. Lower panels for each construct show Cdc28 protein level or ponceau
staining of the membrane as loading control.
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of the SWI5 gene, and clearly indicate the existence of an Mns5-
dependent post-transcriptional mechanism controlling the Swi5 pro-
tein level. This is a speciﬁc characteristic of the Swi5 protein, sinceMsn5 inactivation did not affect the protein content of either the re-
lated Ace2 transcription factor or other cell cycle transcription factors
such as Swi6 andWhi5, the localization of which is regulated by Msn5
(Fig. 5D).
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A previous study of Swi5 suggested that the protein level dimin-
ishes during the G1 phase, which is coincident with its nuclear local-
ization [23]. In addition to periodic SWI5 gene expression, a
posttranscriptional mechanism controlling the Swi5 protein level
throughout the cell cycle must exist, because we observed that Swi5
levels ﬂuctuate when the gene is expressed under the control of the
constitutive PGK1 promoter (Supp. Fig. S2A). The amount of ectopi-
cally expressed Swi5 was minimal in the G1 phase, which is the cell
cycle stage in which Swi5 is nuclear. Taking these observations into
account, it is possible that the reduced level of Swi5 in msn5 mutant
cells was caused by an accumulation of Swi5 in the nucleus, which
would lead to a higher rate of protein degradation. Nonetheless,Fig. 6. Analysis of Swi5 protein stability and synthesis in the msn5 mutant strain. A) The GA
rafﬁnose. Galactose was added to a ﬁnal concentration of 2% and after 40 min cells were tran
the indicated time by western analysis. In the case of the GAL1:HA-SWI5 strain a shorter exp
B) Cycloheximide to a ﬁnal concentration of 50 μg/mL was added to exponentially growing
protein level in crude cell extracts was determined at the indicated time by western ana
is shown as loading control. C) The GAL1:HA-SWI5 (JCY1117) and the GAL1:HA-SWI5 msn5
Synthesis of Swi5 and control Rot1 protein was induced by the addition of galactose to a
mRNA was determined by western analysis (upper panel) and northern analysis (lower pan
Graph represents the amount of Swi5 protein, Rot1 protein and SWI5 mRNA relative to theother results cast doubt on this hypothesis. First, the lower levels of
Swi5 that we detected in msn5 mutant cells could also be observed
in a cytosolic variant of Swi5 (Swi51–634) in which the NLS signal
was eliminated (Fig. 5E and Supp. Fig. S2B). Second, variant proteins
that are mostly nuclear, like truncated Swi5325–709 and a mutated
Swi5 in which Ser 522, 646, and 664 were substituted with Ala
(Swi5AAA), also displayed reduced levels upon Msn5 inactivation
(Fig. 5E). Thus, Swi5 protein levels decreased when Msn5 was inacti-
vated irrespective of protein localization. Finally, analysis of Swi5 pro-
tein decay with either a transcriptional shut-off assay (by adding
glucose to cells containing the GAL1:SWI5 gene) or a translational
shut-off assay (by adding cycloheximide) indicated that the stability
of Swi5 in the msn5 mutant strain did not differ from that observed
in the wild-type strain (Fig. 6A, B and Supp. Fig. S2E). In short,L1:HA-SWI5 (JCY1117) and the GAL1:HA-SWI5 msn5 (JCY1120) strains were grown on
sferred to YPDmedium. The Swi5 protein level in crude cell extracts was determined at
osure of the ﬁlm is also shown. Loading controls of total protein are shown (ponceau).
cultures of the wild type (W303-1a) and the msn5 mutant (JCY1018) strains. The Swi5
lysis. A non-speciﬁc band labeled with an asterisk that cross-react with the antibody
(JCY1120) strains containing the pGAL1:ROT1-HA plasmid were grown on rafﬁnose.
ﬁnal concentration of 2%. The accumulation of the Swi5 and Rot1 proteins and SWI5
el) at the indicated times. Cdc28 and actin mRNA levels are shown as loading controls.
8 hours time point of the wild type strain.
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changes in subcellular localization and by a mechanism distinct to
changes in protein stability.
While performing the transcriptional shut-off experiment de-
scribed above, we observed that Swi5 levels during the synthesis
pulse in galactose medium was low in msn5 mutant cells. To better
characterize this ﬁnding, we analyzed the kinetics of accumulation
of Swi5 in both wild-type and msn5 cells. Cells containing the GAL1:
SWI5 gene were grown on rafﬁnose and Swi5 synthesis was induced
by adding galactose to the medium. As a control, these cells also con-
tained a centromeric plasmid expressing the ROT1 gene under the
control of the same GAL1 promoter. Swi5 and Rot1 protein levels
were analyzed in parallel. As shown in Fig. 6C, accumulation of Swi5
in the absence of Msn5 clearly lagged behind the accumulation of
Swi5 in wild-type cells. The defect in Swi5 accumulation was not
due to defects in GAL1 driven expression, because the control protein
Rot1 accumulated properly in the absence of Msn5. Moreover, north-
ern analysis conﬁrmed that SWI5 mRNA levels were roughly similar
in both the presence or absence of Msn5. The steady-state level of a
protein is the result of the balance between the synthesis and degra-
dation rates. Once we had ruled out protein degradation as the source
of the difference in the Swi5 level between wild-type and msn5
strains, we were able to conclude that Swi5 synthesis takes place at
a reduced rate in msn5 mutant cells.
After establishing that Msn5 controls Swi5 synthesis, we decided
to analyze whether a speciﬁc region of Swi5 mediated this effect.
Thus, levels of various truncated forms of Swi5 were analyzed in
both wild-type and msn5 mutant strains (Fig. 5E). Truncated Swi5
forms encompassing fragments 1–635, 1–551 and 1–422 showed
the characteristic differences between wild-type and msn5 cells.
Thus, the C-terminal part of Swi5 was not required for regulation by
Msn5 and, reciprocally, region 1–422 was sufﬁcient to mediate con-
trol by Msn5. Similarly, the truncated form Swi5326–709 also mani-
fested the reduction in Swi5 levels when Msn5 was inactivated.
However, Swi5422–709 lost this reduction, so that the protein concen-
tration was the same in both msn5 and wild-type cells. TheseFig. 7. Analysis of Swi5 functionality in themsn5mutant strain. A) β-galactosidase activity in
formed with the pHO(31):lacZ plasmid containing the lacZ reporter gene under the contro
from at least 3 independent transformants. B) Expression of SIC1 gene in mid-log cultures o
ACT1 is shown as loading control. C) Expression of SIC1 gene in α-factor synchronized cultur
170, 185, 200 and 220 min after the release. ACT1 is shown as loading control. Graph repreobservations indicate that while neither the N-terminal region
1–325 nor the C-terminal region 422–709 of Swi5 was required for
regulation of Swi5 synthesis by Msn5, fragment 325–422 was impor-
tant for Msn5 control of Swi5 protein levels. Nevertheless, when frag-
ment 325–422 was fused to a GFP protein, it did not confer Msn5-
dependent regulation of protein levels. This suggests that, although
this region was necessary, it was not sufﬁcient to mediate the reduc-
tion in Swi5 levels in msn5 cells; thus, other sequence fragments are
required.
3.6. Swi5 is functional in the msn5 mutant strain
Having determined that the msn5 mutation alters the localization
and concentration of Swi5, we wondered if it also affected the tran-
scriptional activity of the protein. We initially assessed the function-
ality of Swi5 using the reporter gene fusion HO(31): lacZ, which
comprised the coding region of the lacZ gene and the region from
the HO gene promoter necessary for its regulation by Swi5 [18]. The
β-galactosidase activity present in extracts from wild-type and
msn5 strains bearing the HO(31): lacZ gene indicated that, although
the activity achieved in the absence of Msn5 was slightly lower than
that observed in the wild-type strain (probably due to the reduced
amount of protein), Swi5 retained its functionality as a transcription
factor (Fig. 7A).
To further test Swi5 activity, we analyzed SIC1 gene expression. In-
activation of Swi5 strongly affects periodic expression of the SIC1
gene in late mitosis [7,8]. However, inactivation of Msn5 did not
alter global levels or cell-cycle regulation of SIC1 gene expression
(Fig. 7B, C). This is in agreement with the previous result and con-
ﬁrms that Swi5 was functional in the msn5 mutant strain.
3.7. msn5 mutant cells are sensitive to overexpression of Swi5
We envisaged the possibility thatmsn5 cells were sensitive to high
levels of Swi5. To explore this possibility in detail, we analyzed
growth of different GAL1: HA-SWI5 transformants that differed inextracts from wild type (W303-1A), msn5 (JCY1018) and swi5 (JCY920) strains trans-
l of a fragment from HO promoter regulated by Swi5. Values are derived from extracts
f wild type (W303-1A) and msn5 (JCY1018) strains was studied by Northern analysis.
es. Samples were collected at 0, 10, 20 30, 40 50, 60, 70, 80, 90, 100, 110, 125, 140, 155,
sents the budding index as a control of synchronization.
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derived mutants in medium with galactose as the sole carbon source.
While all of the GAL1: HA-SWI5 strains grew in galactose medium, the
msn5 mutant strains displayed heterogeneous behavior ranging from
no growth, poor growth and normal growth (Fig. 8A). Strikingly, the
strength of the growth defect in the msn5 mutant strains correlated
perfectly with the amount of Swi5 in the cell extracts (Fig. 8B). Thus,
the higher the Swi5 content, the lower the growth rate of the GAL1:
HA-SWI5 msn5 strains. This result strongly suggests that themsn5mu-
tant was sensitive to Swi5 in a dose-dependent manner. No accumula-
tion of cells in a speciﬁc cell cycle stage was observed, which suggest
that cells were affected at several cell cycle points or at an essential
function no related to a speciﬁc cell-cycle stage (F.J.T. unpublished
data).
Considering the nuclear localization of Swi5 protein in msn5 mu-
tants, the observation above suggests that abnormal accumulation
of high levels of Swi5 inside the nucleus could prove toxic for cells.
To investigate this possibility, we studied whether the growth defect
on galactose of GAL1: HA-SWI5 msn5 strain could be reverted by
restricting Swi5 localization to the cytoplasm. To do this, we removed
the C-terminal end (amino acids 635–709) containing the NLS from
the GAL1: HA-SWI5 msn5 strain. Elimination of this fragment
completely suppressed the growth defect in this strain (Fig. 8C).
Growth recovery was not due to reduced levels of Swi5, since Swi5
and Swi51–634 levels were equivalent (Fig. 8D). This result strongly
suggests that the toxicity of high amounts of Swi5 in the absence of
karyopherin Msn5 was associated with its accumulation inside the
nucleus.Fig. 8. Effect of Swi5 misregulation on cell growth. A) 10-fold serial dilutions from exponent
the GAL1:HA-SWI5 strain (JCY1117) and their msn5 derived mutant strains were spotted ont
crude extracts of cells from exponentially growing cultures of the GAL1:HA-SWI5 and theirm
total protein is shown (ponceau). C) 10-fold serial dilutions from exponentially growing cu
responding GAL1:HA-SWI51–634 (JCY1235) and GAL1:HA-SWI51–634 msn5 (JCY1237) strains ex
ted onto YPD or YPGal medium and incubated at 28° for 3 days. D) The level of Swi5 protein
analyzed by western analysis. A loading control of total protein is shown (ponceau).4. Discussion
The genetic interactions between themsn5mutant and the mitotic
exit machinery suggest a role for Msn5 at this point in the cell cycle.
Previous results reported by other authors showed that Msn5 inter-
acted with proteins involved in exit from mitosis. For example,
Msn5 was reported to be involved in the regulation of the APC
substrate-recognition subunit Cdh1 [35]. Cdh1 participates in the
degradation of Clb cyclins, a key process in the inactivation of CDKs
at the end of mitosis. Cdh1 is activated at the end of mitosis by phos-
phatase Cdc14 and is inactivated at the beginning of the next cell
cycle by Cln-Cdc28 kinases. Msn5 may contribute to the inactivation
of Cdh1 by assisting in its export from the nucleus. However, this pos-
sibility is not in line with the observed sensitivity of msn5 mutant to
high levels of Clb2. In addition, the genetic interaction detected be-
tween msn5 and a null mutant of CDH1 suggests that Msn5 carries
out other functions in the mitotic exit network irrespective of Cdh1.
In this study, we identiﬁed another protein involved in mitotic exit
that is regulated by Msn5. Msn5 is involved in the regulation of
both the subcellular localization and the cellular concentration of
the transcription factor Swi5 (Supp. Fig. S3).
Control of the subcellular localization of Swi5 is an example of the
spatial regulation mechanisms in cell cycle control. Swi5 is one of the
ﬁrst proteins for which a change in subcellular localization during the
cell cycle was described. It contains a classic NLS at the C-terminal end
of the protein that is regulated by the phosphorylation status of near-
by Ser residues [24]. Once SWI5 gene expression is activated in G2,
Swi5 is restricted to the cytoplasm by phosphorylation of Ser 522,ially growing cultures of wild type (W303-1a), msn5 (JCY1018), four different clones of
o YPD or YPGal medium and incubated at 28° for 3 days. B) The level of Swi5 protein in
sn5 derived strains used in A was determined by western analysis. A loading control of
ltures of the GAL1:HA-SWI5 (JCY1117), its msn5 derived mutant (JCY1120) and the cor-
pressing a Swi5 truncated version of the proteins lacking the NLS sequence, were spot-
in crude extracts of cells from exponentially growing cultures of strains used in C was
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nucleus after Cdc14 phosphatase-mediated dephosphorylation. Our
results provide additional information about the spatial regulation of
Swi5, because they show that yeast cells also control subcellular local-
ization of Swi5 by an Msn5-mediated export mechanism.
Several observations call into question the importance of control
of Swi5 by Msn5, and whether Msn5 itself is important during the
M-G1 transition. First, transcriptional activation by Swi5 was not sub-
stantially affected in msn5mutants. Second, inactivation of Msn5 was
deleterious for growth in mitotic exit mutants that expressed the
Swi51–634 truncated protein lacking the NLS (Supp. Fig. S4), which
suggests that the detected genetic interactions are not related to the
misregulation of Swi5 localization in the msn5 mutant. Moreover,
we observed greater sensitivity to overexpression of Clb2 in the
msn5 swi5 double-mutant strain compared to single mutants (Supp.
Fig. S4); this indicates that the effect of the msn5 mutation was not
mediated through regulation of Swi5 alone. Third, despite numerous
genetic interactions with mitotic exit genes or control of the subcellu-
lar localization of Swi5 and Cdh1, Msn5 inactivation had no apparent
effect on the kinetics of the telophase/G1 transition, as deduced from
analysis of the cell cycle progression of msn5 cdc15 double mutants
compared to cdc15 mutants after release from telophase arrest
(F.J.T. unpublished data). This observation suggests that the role
played by Msn5 in mitotic exit may be dispensable, unless the robust-
ness of the transition is weakened by mutations in a component of
this regulatory system. However, the export of Swi5 by Msn5 is in-
deed relevant for cellular physiology. A stable variant of Swi5 was re-
cently reported to cause defects in the G1-S transition [27]. This
observation suggests that high levels of Swi5 may have a deleterious
effect on cells. More importantly, the toxic effect of high Swi5 activity
was strongly exacerbated in the absence of Msn5, regardless of the re-
duced amount of the Swi5 protein. This could be because the toxicity
of Swi5 was due to its nuclear accumulation, which was supported by
the ﬁnding that restricting nuclear import completely alleviated Swi5
toxicity in msn5 mutant cells. If we consider that Swi5 is active as a
transcriptional activator in the absence of Msn5, we can speculate
that unscheduled Swi5-dependent transcription is toxic and that
Swi5 export by Msn5 helps to restrict the period during which this ac-
tivity takes place. For example, Swi5 export by Msn5 could contrib-
ute, together with degradation of the protein, to the inactivation of
Swi5 during G1/S. Additionally, export of Swi5 may be important for
avoiding premature activation of target genes. Swi5 and Clb2 are syn-
thesized in the G2 phase at the same time; therefore, it is conceivable
that some Swi5 molecules could enter the nucleus before Clb2 blocks
its NLS, even more so if we consider that Clb2 is mostly nuclear. Thus,
Swi5 export by Msn5 could act as a security mechanism by excluding
those Swi5 molecules that eluded Clb2-mediated nuclear import inhi-
bition from the nucleus in order to avoid premature activation of
Swi5 target genes.
In addition to the spatial regulation of Swi5, Msn5 also participates
in regulating Swi5 protein levels. msn5 mutant cells had lower Swi5
levels compared to wild-type cells. The fact that this effect was ob-
served in msn5 mutant strains with no growth defect and that Swi5
level diminished quickly in parallel to Msn5 decay clearly indicate
that detection of low amounts of Swi5 is not correlated to grow de-
fect. The decay in Swi5 level was not due to alterations in transcrip-
tion of the SWI5 gene; rather, it occurred at the posttranscriptional
level. Previous work on Swi5 suggested a model whereby Swi5 was
gradually degraded inside the nucleus during G1 until it disappeared,
which would explain the drop in Swi5 protein levels in this phase
[23,24]. Therefore, it is conceivable, in principle, that nuclear accumu-
lation of Swi5 in msn5 mutant cells could lead to greater protein in-
stability and, consequently, to lower Swi5 cellular levels. However,
several results have contradicted this model, particularly with regard
to Swi5 degradation being due to its nuclear import during G1. For ex-
ample, we observed that a truncated version of Swi5 that is mainlylocalized in the cytoplasm (Swi51–634) had reduced protein levels
during G1 (Supp. Fig. S2C). This suggests that Swi5 instability during
G1 is not dependent, or at least not totally, on its nuclear location. Ac-
cordingly, blocking nuclear import of Swi5 in the cse1 mutant strain
(Cse1 is a component of the classical import pathway) does not stabi-
lize Swi5 [49]. In fact, we observed that deletion of the NLS had no ef-
fect on the protein's half-life (Supp. Fig. S2D). Furthermore, we
describe how the drop in Swi5 protein levels caused by Msn5 inacti-
vation also occurred in the nuclear and cytosolic versions of the pro-
tein, which suggests that the effect of Msn5 on the Swi5 level is
independent of the control of subcellular localization. The ﬁndings re-
garding Swi5326–709 are particularly interesting, since this truncated
version of Swi5 did not interact with Msn5 in the two-hybrid assay,
which supports the conclusion that protein level control is indepen-
dent of subcellular localization control. Finally, the shut-off experi-
ments demonstrated that the stability of Swi5 was not affected in
the msn5 strain. All of these observations led us to rule out the possi-
bility that an increased rate of degradation as the result of altered lo-
calization was the cause of the reduced amount of Swi5 in msn5 cells.
Instead, the results indicate that problems in Swi5 protein synthesis
arose when Msn5 was absent. If excess nuclear Swi5 is indeed toxic
for cells, the concomitant protein level reduction accompanying its
nuclear accumulation when exportin Msn5 is absent may be an evo-
lutionary advantage.
Typically, mRNA is regulated by sequences present in the 5′- or 3′-
unstranslated regions. For Swi5 regulation by Msn5, however, neither
substitution of the 5′-UTR (GAL1 constructs) nor the 3′-UTR (C-termi-
nal epitope-tagged proteins) eliminated the drop in Swi5 levels in the
msn5 mutant strain. Thus, the effect of Msn5 on the Swi5 synthesis
rate must be mediated by sequences in the coding region. In support
of this, we show that the region coding for amino acids 326–422 was
required for control of Swi5 synthesis. Different scenarios can be en-
visaged as to how Msn5 could control Swi5 synthesis (Supp. Fig.
S3B). Absence of exportin Msn5 could prevent the nuclear exit of spe-
ciﬁc factors required for either proper SWI5 mRNA processing or
translation in the cytoplasm. A physical interaction has been reported
between Msn5 and Vts1 [48], a protein that can interact with RNA
[50]. However, inactivation of msn5 decreased Swi5 protein levels
even in the absence of Vts1 (Supp. Fig. S5). Alternatively, Msn5
could directly affect SWI5 mRNA nuclear export. Although the
mRNA export pathway is dependent on receptor Mex67-Mtr2
(reviewed in [51], Msn5 has been shown to bind RNA molecules in
vitro [45]. Therefore, a direct role for Msn5 in the export of speciﬁc
mRNAs cannot be ruled out. In addition, Msn5 may affect tRNA so
that the translation rate of speciﬁc messengers decreases in its ab-
sence. A good candidate for mediation of tRNA control is Maf1, a re-
pressor of RNApol III, the nuclear export of which is mediated by
Msn5 [43]. However, msn5 affected Swi5 protein levels even in the
absence of Maf1 (Supp. Fig. S5). Msn5 was reported to bind tRNA
and to play a role in tRNA export [44,45]. Inactivation of Msn5 could
alter the cytosolic pools of tRNA and affect the translation of speciﬁc
sequences in SWI5 and other mRNAs. Future studies could help to elu-
cidate howMsn5 affects Swi5 synthesis and to identify additional tar-
gets under Msn5 control.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.bbamcr.2012.02.009.
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